STAT - Reporting from the frontiers of health and medicine

Special Report

By Natasha Gilbert

Adam's Take

Off the Charts

Biotech FDA approves Amarin fish-oil-derived drug to prevent heart attacks and strokes
Biotech Something Ventured: Akrevia Therapeutics and three other startups got venture funding a year ago. Did it help them do what they said it would?
First Opinion BMJ should retract flawed research paper on chronic fatigue syndrome
Health Surgeons test-drive the amputation of the future with a mail-order limb, rerouted nerve, and prosthetic hand that grips like the real thing
Biotech Biotech veteran Chris Garabedian on Sarepta’s legacy and Biogen’s future at the FDA

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Amid fears of superbugs, sales of antibiotics used in food-producing livestock rose last year
U.S. Patent Office removes lawyer from high-profile case involving a Gilead HIV medicine
PhRMA sues Oregon over drug pricing transparency laws, calling them ‘unconstitutional’

Health

Health

Health

Health

Don't Miss

By STAT

Special Report

First Opinion Machine learning for clinical decision-making: pay attention to what you don’t see
Health Why fentanyl is deadlier than heroin, in a single photo
Biotech FDA approves Amarin fish-oil-derived drug to prevent heart attacks and strokes
First Opinion Do large pharma companies provide drug development innovation? Our analysis says no
First Opinion BMJ should retract flawed research paper on chronic fatigue syndrome